William B. Parker - Publications, H-index & Citations

William B. Parker

University of Central Florida

41H指数

197论文数

5.9K被引数

收录论文 45

发表时间

5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic Best-in-Class: DNA Methyltransferase 1-Depleting Agent in Clinical Development

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2021-12-01

OAAI

Parker, William B.; Thottassery, Jaideep V.

Regarding Comparison of the Number of Spindle Cells in Peritoneal Washings between Laparoscopic Myomectomy with Morcellation and Open Myomectomy without Morcellation

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY

IF3.3

2021-12-01

PREAI

Parker, William; Siedhoff, Matthew; Pritts, Elizabeth

6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2016-01-01

PREAI

Hassan, Abdalla E. A.; Abou-Elkhair, Reham A. I.; Parker, William B.; Allan, Paula W.; Secrist, John A., III

Thiarabine, 1-(4-Thio-β-D-arabinofuranosyl)cytosine. A Deoxycytidine Analog With Excellent Anticancer Activity

CURRENT MEDICINAL CHEMISTRY

IF3.5

2015-11-19

PREAI

Parker, W. B.; Waud, W. R.; Secrist, J. A., III

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

ANNALS OF ONCOLOGY

IF65.4

2015-07-01

OAAI

Rosenthal, E. L.; Chung, T. K.; Parker, W. B.; Allan, P. W.; Clemons, L.; Lowman, D.; Hong, J.; Hunt, F. R.; Richman, J.; Conry, R. M.; Mannion, K.; Carroll, W. R.; Nabell, L.; Sorscher, E. J.

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity Current strategies

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-27

137

OAAI

Bertino, Joseph R.; Waud, William R.; Parker, William B.; Lubin, Martin

Pre-clinical development of 4′-thio-2′-deoxycytidine (TdCyd) as a DNA-demethylating agent for use in treating solid tissue tumors

CANCER RESEARCH

IF16.6

2014-10-01

PREAI

Kinders, Robert J.; Hollingshead, Melinda; Thottassery, Jaideep; Parker, William B.; Pfister, Thomas D.; Anderson, Lawrence W.; Tomaszewski, Joseph E.; Collins, Jerry M.; Doroshow, James H.

New insights into the synergism of nucleoside analogs with radiotherapy

RADIATION ONCOLOGY

IF3.2

2013-09-26

OAAI

Lee, Michael W.; Parker, William B.; Xu, Bo

Robot-Assisted Laparoscopic Myomectomy Compared With Standard Laparoscopic Myomectomy

OBSTETRICS AND GYNECOLOGY

IF4.7

2013-01-01

PREAI

Kivnick, Seth; Parker, William

Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage

NUCLEIC ACIDS RESEARCH

IF13.1

2012-07-31

OAAI

Yang, Chunying; Lee, Michael; Hao, Jianwei; Cui, Xiaoli; Guo, Xiaojing; Smal, Caroline; Bontemps, Francoise; Ma, Shumei; Liu, Xiaodong; Engler, David; Parker, William B.; Xu, Bo

A physiologically relevant 3D cell culture model for screening anti-cancer compounds

CANCER RESEARCH

IF16.6

2012-04-01

PREAI

Yan, Jiyu; Parker, William B.; Suto, Mark J.; Padmalayam, Indira

Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: Palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides [1]

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2012-01-01

OAAI

Hassan, Abdalla E. A.; Abou-Elkhair, Reham A. I.; Riordan, James M.; Allan, Paula W.; Parker, William B.; Khare, Rashmi; Waud, William R.; Montgomery, John A.; Secrist, John A., III

Gingival enlargement

JOURNAL OF THE AMERICAN DENTAL ASSOCIATION

IF3.5

2011-11-01

PREAI

Pette, Gregory A.; Siegel, Michael A.; Parker, William B.

Novel 2′-deoxycytidine analogs as DNA demethylation agents

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Thottassery, Jaideep V.; Tiwari, Kamal; Westbrook, Louise; Secrist, John A.; Parker, William B.

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase

CANCER GENE THERAPY

IF5

2011-03-11

OAAI

Parker, W. B.; Allan, P. W.; Waud, W. R.; Hong, J. S.; Sorscher, E. J.

Cryopreserved Amniotic Membrane for Modulation of Periodontal Soft Tissue Healing: A Pilot Study

JOURNAL OF PERIODONTOLOGY

IF3.8

2010-12-01

PREAI

Velez, Ines; Parker, William B.; Siegel, Michael A.; Hernandez, Maria

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

CANCER GENE THERAPY

IF5

2010-05-14

OAAI

Tai, C-K; Wang, W.; Lai, Y-H; Logg, C. R.; Parker, W. B.; Li, Y-F; Hong, J. S.; Sorscher, E. J.; Chen, T. C.; Kasahara, N.

Structure-activity relationship for adenosine kinase from Mycobacterium tuberculosis.: II.: Modifications to the ribofuranosyl moiety

BIOCHEMICAL PHARMACOLOGY

IF5.6

2008-04-01

OAAI

Long, Mary C.; Shaddix, Sue C.; Moukha-Chafiq, Omar; Maddry, Joseph A.; Nagy, Lisa; Parker, William B.

Lymphoma chemovirotherapy: CD20-Targeted and ConvertaseArmed measles virus can synergize with fludarabine

CANCER RESEARCH

IF16.6

2007-11-15

OAAI

Ungerechts, Guy; Springfeld, Christoph; Frenzke, Marie E.; Lampe, Johanna; Johnston, Patrick B.; Parker, William B.; Sorscher, Eric J.; Cattaneo, Roberto

Ribavirin reveals a lethal threshold of allowable mutation frequency for hantaan virus

JOURNAL OF VIROLOGY

IF3.8

2007-11-01

OAAI

Chung, Dong-Hoon; Sun, Yanjie; Parker, William B.; Arterburn, Jeffrey B.; Bartolucci, A.; Jonsson, Colleen B.

研究方向